Evidence mapPaperPMID 42534423Full record

ArticleJournal of clinical and translational science2026

Patients' preferences and perceptions of point-of-care technologies: Survey results from the lung disease community.

Bernard Ofosuhene, Heaven Tatere, Miraf Yeshaneh Tatere, Taylor Orwig, Ziyue Wang, Apurv Soni, Craig M Lilly, Stephen Anders, Denise Dunlap, Honghuang Lin and 7 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bernard OfosuheneUMass Chan Medical School, Worcester, MA, USA.
Heaven TatereUMass Chan Medical School, Worcester, MA, USA.
Miraf Yeshaneh TatereUMass Chan Medical School, Worcester, MA, USA.ORCID https://orcid.org/0009-0005-9087-9964
Taylor OrwigUMass Chan Medical School, Worcester, MA, USA.
Ziyue WangUMass Chan Medical School, Worcester, MA, USA.
Apurv SoniUMass Chan Medical School, Worcester, MA, USA.
Craig M LillyUMass Chan Medical School, Worcester, MA, USA.
Stephen AndersUMass Chan Medical School, Worcester, MA, USA.
Denise DunlapUniversity of Massachusetts Lowell, Lowell, MA, USA.
Honghuang LinUMass Chan Medical School, Worcester, MA, USA.
Allan WalkeyUMass Chan Medical School, Worcester, MA, USA.
Chiara GhezziUniversity of Massachusetts Lowell, Lowell, MA, USA.
Mary Ann PicardUniversity of Massachusetts Lowell, Lowell, MA, USA.
Varun AyyaswamiUMass Chan Medical School, Worcester, MA, USA.
Bryan BuchholzUniversity of Massachusetts Lowell, Lowell, MA, USA.
David D McManusUMass Chan Medical School, Worcester, MA, USA.
Nathaniel HaferUMass Chan Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0002-0164-5092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Point-of-care technology (POCT) has expanded rapidly, particularly since the COVID-19 pandemic. However, less is known about which POCT applications and features patients and caregivers prioritize for lung disease management. Methods: We refined a patient-facing survey based on feedback from an online focus group recruited through community and advocacy volunteer networks. The survey was then administered via ResearchMatch to uncompensated U.S. volunteers, who indicated interest in lung disease research (April 1 to May 14, 2025; 6,333 invitations). POCT perceptions were measured via a 10-point Likert scale. Results: We received 214 responses (3.4% response rate). Respondents were predominantly patients (79%), female (71%), and older than 60 years (59%). Mean ratings suggested strong perceived benefits across nine POCT benefits and low concern across most drawbacks. The greatest concern was insurance coverage for POCT-associated costs (mean score: 6.7/10). Obstructive lung conditions were most frequently prioritized for future POCT applications. Conclusion: Among a national sample of ResearchMatch volunteers affected by lung disease, interest in POCT was high, and insurance coverage remained the most salient concern. By describing preferences and concerns of patients, this study informs future design, regulatory approval, and clinical integration. These findings provide evidence for POCT developers, clinicians, and policymakers focused on improving patient-centered care.

Indexed as

covid-19 pandemicPoint-of-care testrespiratory diseases

Identifiers

PMID42534423
PMCPMC13420163

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.